Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × Dasatinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Burkitt Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Chronic-Phase 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Cyclophosphamide 2 sodium-iodide symporter 1 selinexor 1 relatlimab 1 fludarabine 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 belinostat 1 X-Rays 1 Specimen Handling 1 Salvage Therapy 1 Prednisone 1 Photons 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Immunoglobulin G 1 Doxorubicin 1 Disulfides 1 CTLA-4 Antigen 1 Brentuximab Vedotin 1 Biopsy 1 Azacitidine 1 Abatacept 1 ASTX-660 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡